Global Oral Proteins and Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Oral Proteins and Peptides Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.



According to our (Global Info Research) latest study, the global Oral Proteins and Peptides market size was valued at US$ 3054 million in 2023 and is forecast to a readjusted size of USD 7903 million by 2030 with a CAGR of 14.7% during review period.

Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

This report is a detailed and comprehensive analysis for global Oral Proteins and Peptides market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:

Global Oral Proteins and Peptides market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030

Global Oral Proteins and Peptides market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030

Global Oral Proteins and Peptides market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (US$/Mg), 2019-2030

Global Oral Proteins and Peptides market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (US$/Mg), 2019-2024

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Oral Proteins and Peptides

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Oral Proteins and Peptides market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Oral Proteins and Peptides market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Linaclotide
Insulin
Plecanatide
Cyclosporine
Octreotide

Market segment by Application
Gastric & Digestive Disorders
Bone Diseases
Diabetes
Hormonal Disorders

Major players covered
Ironwood & Allergan
Novo Nordisk
Synergy Pharmaceuticals （Salix）
Novartis
Chiasma (Amryt Pharma)

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Oral Proteins and Peptides product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Oral Proteins and Peptides, with price, sales quantity, revenue, and global market share of Oral Proteins and Peptides from 2019 to 2024.

Chapter 3, the Oral Proteins and Peptides competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Oral Proteins and Peptides breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Oral Proteins and Peptides market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Oral Proteins and Peptides.

Chapter 14 and 15, to describe Oral Proteins and Peptides sales channel, distributors, customers, research findings and conclusion.